Cargando…
Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells
BACKGROUND: Canine urothelial carcinoma is the most common form of canine bladder cancer. Treatment with chemotherapy has variable response rates leading to most dogs succumbing to their disease within a year. Cannabidiol is an emerging treatment within the field of oncology. In reported in vivo stu...
Autores principales: | Inkol, Jordon M., Hocker, Samuel E., Mutsaers, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341525/ https://www.ncbi.nlm.nih.gov/pubmed/34352013 http://dx.doi.org/10.1371/journal.pone.0255591 |
Ejemplares similares
-
Effects of the potassium‐sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells
por: Poon, Andrew C., et al.
Publicado: (2018) -
Combinations of Cannabidiol and Δ(9)-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
por: Sepulveda, Diana E., et al.
Publicado: (2022) -
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023) -
The miRNome of canine invasive urothelial carcinoma
por: Varvil, Mara S., et al.
Publicado: (2022) -
Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies
por: Sommer, Breann C., et al.
Publicado: (2018)